JAK Inhibitors for Crohn's Disease: A Systematic Review and Dose-Response Network Meta-Analysis of Efficacy and Safety. [PDF]
Qtaishat FA +12 more
europepmc +1 more source
Upadacitinib for atopic dermatitis induced by secukinumab in patients with refractory ankylosing spondylitis:a case report. [PDF]
Fang J, Pan S.
europepmc +1 more source
Upadacitinib for Refractory Anti-melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis-Related Interstitial Lung Disease. [PDF]
Morikawa K +3 more
europepmc +1 more source
First Reported Case of Upadacitinib-Associated Cytomegalovirus Viremia and Suspected Pneumonitis in Ulcerative Colitis. [PDF]
Javier-Rojas WJ +6 more
europepmc +1 more source
Necrotizing scleritis resistant to biologics successfully managed with the JAK inhibitor upadacitinib: a case report. [PDF]
Oyama T +4 more
europepmc +1 more source
Successful treatment of cutaneous small-vessel vasculitis with upadacitinib: a Case Report. [PDF]
Li X +6 more
europepmc +1 more source
Janus Kinase Inhibitors for Treatment of Palmoplantar Pustulosis, Generalized Pustular Psoriasis, and Palmoplantar Pustular Psoriasis: A Systematic Review of the Literature. [PDF]
Ansari MS +5 more
europepmc +1 more source
Preclinical models of hepatosplenic γδ T-cell lymphoma with an activating STAT5B mutation display sensitivity to JAK inhibitor upadacitinib. [PDF]
Aung MMK +32 more
europepmc +1 more source
Related searches:

